HOUSTON, Dec. 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the ...
As reported by Pulse and DailyPharm Korea, Celltrion recently filed an Investigational New Drug (IND) application with the FDA for a global Phase 3 clinical trial aimed at demonstrating its biosimilar ...
Immuneering Corporation IMRX announced that it has submitted an investigational new drug (IND) application to the FDA to begin a clinical study on its lead product candidate IMM-1-104 for the ...
HOUSTON, TX / ACCESS Newswire / March 4, 2026 / BrYet US, Inc. (“BrYet”) – a biotechnology innovator focused on developing curative therapies for advanced cancers – announced today that it has filed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results